[Comparative evaluation of the effect of etimizol and intal in the treatment of bronchial asthma].
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D002256:Carbonic Anhydrases / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004341:Drug Evaluation; D005042:Etimizol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012119:Respiration; D014168:Transferrin / Q000032:analysis
D007093:Imidazoles; D014168:Transferrin; D002570:Ceruloplasmin; D002256:Carbonic Anhydrases; D005042:Etimizol; D004205:Cromolyn Sodium
Sravnitel'naia otsenka deĭstviia etimizola i intala pri lechenii bronkhial'noĭ astmy